Retour

Explorez tous les épisodes du podcast Science For The Real World: Canadian Hematology Today

Plongez dans la liste complète des épisodes de Science For The Real World: Canadian Hematology Today. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–5 of 5

TitreDateDurée
Prise en charge des patients atteints de LLC doublement exposée et réfractaire.18 Nov 202500:16:48

Hosted on Acast. See acast.com/privacy for more information.

Addressing the management of patients with double exposed and refractory CLL18 Nov 202500:17:40
Sponsored by Eli Lilly

Hosted on Acast. See acast.com/privacy for more information.

CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection24 Sep 202500:24:35
Sponsored by Bristol Myers Squibb.

Hosted on Acast. See acast.com/privacy for more information.

Practical considerations in the management of early rrMM in the Canadian context06 Jan 202500:32:00

This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context.


This episode of Science for the Real World is part of Canadian Hematology Today, an open-access scientific journal for the hematology community.

Hosted on Acast. See acast.com/privacy for more information.

The role of selinexor in early rrMM and sequencing in 2024.26 Jun 202400:27:34

In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.


Hosted on Acast. See acast.com/privacy for more information.

© My Podcast Data · Projet indépendant · Données issues d'Apple & Spotify